Kyle Gano, Chief Executive Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 300 shares at $141.97 ($43K) on 2025-11-04, disclosed to the SEC on 2025-11-04.
Scheduled sale ($43k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $471K | — | Filing → |
| NBIX | SELL | 2025-01-17 | $9.2M | — | Filing → |